Scheriproct

Scheriproct is a rectal medication combining Cinchocaine Hydrochloride and Prednisolone Caproate. It is used for local relief of pain and inflammation in conditions like hemorrhoids and anal fissures. This product is manufactured by Karo Pharma AB in the EU.

Scheriproct is primarily used for the relief of pain and inflammation in the rectal area. It is often recommended for conditions such as hemorrhoids and anal fissures. The combination of Cinchocaine Hydrochloride and Prednisolone Caproate works to provide both numbing and anti-inflammatory effects, making it suitable for various rectal discomforts.

Users of Scheriproct may experience relief from pain and inflammation in the rectal area. The medication works locally to numb the area and reduce swelling. Some users might notice a reduction in discomfort and itching associated with hemorrhoids or anal fissures.

Scheriproct should be used as directed by a healthcare professional. It is important to follow the recommended usage guidelines to avoid potential side effects. Users should be aware of any allergic reactions to the ingredients and consult a healthcare provider if symptoms persist or worsen.

Scheriproct may interact with other medications, especially those that affect the rectal area. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods might also affect the efficacy of the medication.